By Pierre Little

The Méditerranée Infection University Hospital Institute in Marseille in France have published their open-label non-randomized clinical trial on COVID-19 treatment using hydroxychloroquine and azithromycin.  This would seem to be saying it is a cure for the infection in some cases.  Hydroxychloroquine sold as Plaquenil is used for malaria treatment and Rheumatoid Arthritis. 

Bloomberg is reporting that Apotex is donating 250,000 doses to front-line medical staff, doctors and nurses.

We have published an early report on this drug March 17. A Possible Effective Treatment for Coronavirus (COVID-19) ​

The study says:

100% of patients treated with hydroxychloroquine and azithromycin combination were virologically cured comparing with 57.1% in patients treated with hydroxychloroquine only, and 12.5% in the control group... 

and

We therefore recommend that COVID-19 patients be treated with hydroxychloroquine and azithromycin to cure their infection and to limit the transmission of the virus to other people in order to curb the spread of COVID-19 in the world.

Open-label non-randomized clinical trial can be read online here: https://www.sciencedirect.com/science/article/pii/S0924857920300996

Recent Anecdotal Evidence

https://nypost.com/2020/03/22/florida-man-with-coronavirus-says-drug-tou...